Extremity preservation by combined modality treatment of sarcomas of the hand and wrist.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 3771312)

Published in Int J Radiat Oncol Biol Phys on November 01, 1986

Authors

P Okunieff, H D Suit, K H Proppe

Articles by these authors

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res (1989) 12.85

Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med (1995) 3.43

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39

A clinical and pathological staging system for soft tissue sarcomas. Cancer (1977) 3.19

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys (1995) 3.05

Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res (1999) 2.10

Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09

Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer (1984) 1.94

Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature. J Urol (1981) 1.82

Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst (1993) 1.76

Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer (1975) 1.73

Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys (1995) 1.73

Management of patients with sarcoma of soft tissue in an extremity. Cancer (1973) 1.63

Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62

Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res (1989) 1.60

Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res (2001) 1.59

Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys (1995) 1.58

Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys (1998) 1.56

Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology (1980) 1.53

Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am (1993) 1.52

Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol (1993) 1.51

Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer (1987) 1.49

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg (1999) 1.46

Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg (1982) 1.44

Gorham's massive osteolysis: the role of radiation therapy and a review of the literature. Int J Radiat Oncol Biol Phys (1993) 1.43

Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys (2001) 1.34

Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight cases. Am J Surg Pathol (1984) 1.31

Clinical and pathologic review of 48 cases of chordoma. Cancer (1985) 1.30

Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1984) 1.30

Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25

Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. Radiat Res (1989) 1.23

Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (2001) 1.19

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16

Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiation. Cancer (1970) 1.16

Evaluation of rapid radiation treatment schedules utilizing two treatment sessions per day. Radiology (1975) 1.15

Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone. J Bone Joint Surg Am (1999) 1.14

Intratumoral heterogeneity of malignant gliomas measured in vitro. Int J Radiat Oncol Biol Phys (1993) 1.14

Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol (1993) 1.13

Preoperative radiation therapy for sarcoma of soft tissue. Cancer (1981) 1.12

Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice. J Neurosurg (1995) 1.12

Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer (1991) 1.11

Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys (1999) 1.11

The American Society of Therapeutic Radiologists Presidential Address: October 1981. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer (1982) 1.10

Radiation therapy alone for sarcoma of soft tissue. Cancer (1985) 1.09

Vitamin A and the radiation response of experimental tumors: an immune-mediated effect. J Natl Cancer Inst (1972) 1.09

Large-cell calcifying Sertoli cell tumor of the testis. Am J Clin Pathol (1980) 1.09

Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma. Radiat Res (1971) 1.09

Radiation therapy of soft tissue sarcomas. Cancer (1975) 1.08

Sarcoma of bone and soft tissue following treatment of Hodgkin's disease. Cancer (1984) 1.07

Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer (1986) 1.06

Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of a squamous-cell carcinoma of C3H mice. Radiology (1967) 1.04

Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost +/- resection. Int J Radiat Oncol Biol Phys (1983) 1.04

Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet (1993) 1.04

Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol (1977) 1.04

Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery. Semin Oncol (1997) 1.02

Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors. Cancer Res (1990) 1.01

Nonspecific immunotherapy by Corynebacterium parvum: phase I toxicity study in 12 patients with advanced cancer. Cancer (1976) 1.00

A new miniature x-ray device for interstitial radiosurgery: dosimetry. Med Phys (1996) 0.99

Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer (1982) 0.99

Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer (1975) 0.99

Animal systems for translational research in radiation oncology. Acta Oncol (1999) 0.99

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. J Clin Oncol (2003) 0.99

Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys (1990) 0.98

Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/sed mouse to radiation. Radiat Res (1985) 0.98

Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Cancer Res (2001) 0.97

Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate. Science (1997) 0.96

Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status. Int J Radiat Oncol Biol Phys (1986) 0.96

Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol (1995) 0.96

Blood flow, tissue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth. Adv Exp Med Biol (1989) 0.95

Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo. Cancer Res (1979) 0.95

Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys (1986) 0.95

Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth. Nat Med (1996) 0.95

Current results of proton beam irradiation of uveal melanomas. Ophthalmology (1985) 0.95

Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys (1997) 0.94

Benign metastasizing meningioma. Case report. J Neurosurg (1985) 0.94

Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res (1989) 0.94

Malignant fibrous histiocytoma and pleomorphic sarcoma in association with medullary bone infarcts. Cancer (1978) 0.94

Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol (1992) 0.94

Radiation therapy in the treatment of difficult giant cell tumors. Int J Radiat Oncol Biol Phys (1989) 0.94

Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J Surg Oncol (1997) 0.93

Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives. Cancer Res (1997) 0.93

Proliferation kinetics of x-irradiated mouse L cells studied with time-lapse photography. I. Experimental methods and data analysis. Int J Radiat Biol Relat Stud Phys Chem Med (1967) 0.92

Soft part tumors. Cancer (1977) 0.92

Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis (2001) 0.92

Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning. Int J Radiat Oncol Biol Phys (1989) 0.92

Impact of improved local control on survival. Int J Radiat Oncol Biol Phys (1986) 0.92

Potential for hyperthermia and radiation therapy. Cancer Res (1979) 0.91

Metastatic ependymoma of the sacrum. Cancer (1990) 0.91

Ewing's sarcoma: surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys (1988) 0.90

Assessment of the response of tumours to radiation: clinical and experimental studies. Br J Cancer Suppl (1980) 0.90

Ewing's sarcoma in female siblings. A clinical report and review of the literature. Cancer (1984) 0.90

Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res (1993) 0.90

Twice-a-day radiation therapy for cancer of the head and neck. Cancer (1985) 0.90

Proliferation kinetics of x-irradiated mouse L cells studied WITH TIME-lapse photography. II. Int J Radiat Biol Relat Stud Phys Chem Med (1969) 0.90

Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed (1994) 0.90

The potential role of proton beams in radiation oncology. Semin Oncol (1997) 0.90